Bertilimumab

Biologics and Immunomodulators for Immunobullous Diseases
Immunobullous Diseases
by Nishad Sathe, MD on
At ODAC 2023, we had the opportunity to learn about the latest in treatments for blistering diseases from Dr. Karl Saardi, Associate Professor and Director of Inpatient Dermatology at George Washington University. We focused on the pemphigus and pemphigoid group of diseases, which we will review and summarize here. Pemphigus The pemphigus group of diseases is characterized by intraepidermal auto …